Prasad S. Adusumilli, MD, FACS FCCP

Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Deputy Chief and Associate Attending, Thoracic Surgery
Director, Mesothelioma Program
Member, Exp. Therapeutics Center & Centers for Cell Engineering & Cellular Therapeutics
Memorial Sloan-Kettering Cancer Center

Dr. Adusumilli is an Associate Attending and Deputy Chief of the Thoracic Service in the Department of Surgery as well as Director of the Mesothelioma Program at Memorial Sloan Kettering Cancer Center (MSK) in New York. His laboratory research focuses primarily on tumor immunology and the development of chimeric antigen receptor (CAR) T-cell-mediated immunotherapy for thoracic malignancies, specifically non-small cell lung cancer, mesothelioma, and metastatic breast cancer. Over the years, his team has developed clinically-relevant mouse models and modeled novel biological therapies in these models. This research has yielded mechanistic data that has been translated and is now in clinical trials for patients with lung adenocarcinoma, pleural mesothelioma, and breast cancer.

Dr. Adusumilli’s laboratory research has been funded by federal agencies and private foundations resulting in >50 grant awards to date totaling >$30MM to date. His research has resulted in multiple clinical trials to date with >150 publications including in Cancer Discov, FASEB, J Clin Invest, J Clin Oncol, J Natl Cancer Inst, Nat Med, and Sci Transl Med. In addition to serving on medical journal editorial boards, Dr. Adusumilli is the Deputy Editor for Molecular Therapy Oncolytics. He serve as a member of national peer-review committees including NCI, DoD, PCORI, National health institutions of Austria, Belgium, Ireland, Italy, Poland, Netherlands, Switzerland, and the United Kingdom. He is a member of prestigious Fleischner Society and serve on several international committees including the American Society of Cell and Gene Therapy, NCI thoracic cancers steering committee, and the American Association for Thoracic Surgery. In his laboratory, Dr. Adusumilli has mentored 25 MDs, 12 MD/PhDs, and 6 PhDs in thoracic oncology research, including several visiting scholars from multiple international institutions.

Terms of Appointment: Sept 2017 - Aug 2019